Drug intelligence / Profile preview

Changan Granules

Development stage
Phase 2
Lead developer
Shanghai Traditional Chinese Medicine Dayuanchuang Technology
Modality
Small Molecules
Administration
Oral
01

Overview

Changan Granules is a Traditional Chinese Medicine (TCM) formulation developed by Shanghai Traditional Chinese Medicine University Yuanchuang Technology Co., Ltd. specifically for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D). The formula is derived from the classical TCM prescription "Tongxie Yaofang," which has been modified to better address the pathophysiology of IBS-D, including abdominal pain and frequent loose stools. Its mechanism of action is multi-targeted, involving the reduction of visceral hypersensitivity, modulation of the brain-gut axis, and regulation of intestinal permeability and gut microbiota. Clinical studies have indicated that Changan Granules can significantly improve the IBS-D Symptom Severity Score (IBS-SSS) and patient quality of life by inhibiting mast cell activation and regulating serotonin (5-HT) levels in the colonic mucosa.

Brand names
Changan Granules
Other names
Changan KeliChang-An-Ke-LiChang'an Granule
02

Targets

5-HT (Serotonin receptors)

Beyond the preview

Go deeper on Changan Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Changan Granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call